Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the Treatment With Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss on Diabetic and Prediabetic Patients With Obesity Class III

NCT03968224 is registered in ClinicalTrials.gov with Centro Medico Nacional Siglo XXI IMSS as lead sponsor.

NCT NCT03968224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03968224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the Treatment With Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss on Diabetic and Prediabetic Patients With Obesity Class III
Lead sponsor
Centro Medico Nacional Siglo XXI IMSS
Phase
Phase 2/3
Overall status
Completed
Start date
August 4, 2018
Completion date
July 31, 2024
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, obesity, morbid, prediabetes